RESUMEN
UNLABELLED: The present article describes the eye injuries observed in victims of the terrorist attack of 11 March in our hospital. Of the 325 injured individuals who arrived from the sites of explosion, 47 (15%) required specialized ophthalmologic care. Of these 41 were treated on 11 March and the 6 remaining patients were treated on subsequent days. In 5 patients emergency interventions were required. In 3 patients, interventions were delayed. RESULTS: anatomical loss in 1 patient and functional loss in 3 patients.
Asunto(s)
Traumatismos por Explosión/terapia , Servicio de Urgencia en Hospital/organización & administración , Lesiones Oculares/terapia , Hospitales Universitarios/organización & administración , Incidentes con Víctimas en Masa/estadística & datos numéricos , Adolescente , Adulto , Traumatismos por Explosión/complicaciones , Traumatismos por Explosión/epidemiología , Niño , Lesiones Oculares/complicaciones , Lesiones Oculares/epidemiología , Lesiones Oculares/etiología , Femenino , Humanos , Masculino , Persona de Mediana Edad , Oftalmología , España/epidemiología , Resultado del Tratamiento , Recursos Humanos , Adulto JovenRESUMEN
En el artículo describimos las lesiones oculares observadas en los pacientes atendidos en nuestro hospital como consecuencia del atentado terrorista que tuvo lugar el 11 de marzo en Madrid. De los 325 heridos que llegaron desde los diferentes lugares de los atentados, 47 (15%) requirieron atención oftalmológica especializada, 41 de ellos fueron atendidos el 11 de marzo y los 6 restantes en días posteriores. Se intervino de forma urgente a 5 pacientes y a 3 de forma diferida. En cuanto a los resultados, hubo una pérdida anatómica y 3 pérdidas funcionales (AU)
The present article describes the eye injuries observed in victims of the terrorist attack of 11 March in our hospital. Of the 325 injured individuals who arrived from the sites of explosion, 47 (15%) required specialized ophthalmologic care. Of these 41 were treated on 11 March and the 6 remaining patients were treated on subsequent days. In 5 patients emergency interventions were required. In 3 patients, interventions were delayed. Results: anatomical loss in 1 patient and functional loss in 3 patients (AU)
Asunto(s)
Femenino , Humanos , Masculino , Lesiones Oculares Penetrantes/complicaciones , Lesiones Oculares Penetrantes/cirugía , Lesiones Oculares Penetrantes , Cuerpos Extraños en el Ojo/cirugía , Lesiones Oculares/cirugía , Oftalmopatías/cirugía , Lesiones Oculares Penetrantes/epidemiología , Lesiones Oculares Penetrantes/prevención & control , Cuerpos Extraños en el Ojo/diagnóstico , Cuerpos Extraños en el Ojo/terapia , Lesiones Oculares/terapia , Lesiones Oculares , Dolor Ocular , TerrorismoRESUMEN
PURPOSE: Atrial natriuretic peptide (ANP) has been recently described as an endogenous inhibitor of the synthesis and angiogenic action of vascular endothelial growth factor (VEGF). Given VEGF's key role in promoting neovascularization in proliferative diabetic retinopathy (PDR), this study was designed to evaluate the possibility that ANP could be involved in the neovascular and fibrotic complications of PDR. METHODS: We determined ANP by radioimmunoassay in plasma and vitreous humor samples collected from diabetic patients with and without PDR and from non-diabetic subjects. ANP was also immunohistochemically localized in the epiretinal membranes of patients with PDR. RESULTS: Vitreous ANP concentrations were significantly higher in patients with active PDR compared to patients with quiescent PDR, diabetes without PDR or controls <0.05. Significant differences were also observed between vitreous ANP levels in diabetic patients without PDR and control subjects. There was no significant correlation between serum and vitreous ANP levels in any of the patient groups. ANP was detected in the fibrovascular epiretinal tissue of patients with PDR. CONCLUSIONS: Diabetic patients with active neovascularization have significantly higher levels of ANP in the vitreous humor than those without active PDR. Diabetic patients without PDR were also found to have significantly higher vitreous ANP levels than non-diabetic patients. Since plasma and vitreous ANP concentrations were found to be unrelated, we suggest intraocular ANP synthesis and/or an increase in the release of ANP into the vitreous, as opposed to diffusion from the blood, as the main factors contributing to the high vitreous ANP levels observed in diabetic patients. In the fibrovascular epiretinal tissue of these patients, ANP was found to be localized in vascular, glial, fibroblast-like and retinal pigment epithelium cells. Our findings suggest a role for ANP in PDR.